Stock Movers AstraZeneca Up, Puma Rises, Greggs Rallies
Oct 1, 2025
AstraZeneca and other pharmaceutical stocks surged after Pfizer's deal to cut drug prices quelled tariff fears. Puma shares climbed thanks to a strong sales report from Nike, hinting at growing demand in the sportswear market. Meanwhile, Greggs saw its stock soar after a positive trading update for August and September, signaling recovery from earlier struggles. Tune in for insights on these market movers!
AI Snips
Chapters
Transcript
Episode notes
Pfizer Deal Eases Tariff Fears
- Pfizer struck a deal to cut some drug prices in exchange for a three-year pause on tariffs, and markets cheered across pharma names.
- Caroline Hepker and Chloe Malay note European pharma could seek similar deals to avoid steep US tariffs.
Deal Could Be A Pharma Bellwether
- JPMorgan sees Pfizer's deal as a potential bellwether that could let other pharma firms avoid a 100% tariff on branded drugs.
- Caroline Hepker flags Eli Lilly is already in talks, suggesting broader sector impact.
Nike Beat Signals Sportswear Momentum
- Nike's strong sales, especially in running and wholesale, signalled consumer momentum in sportswear that boosted Puma and Adidas shares.
- Stephen Carroll says the market interpreted Nike's beat as a positive read-through for European rivals despite China weakness.